Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Neoadjuvant HER2+
Brain Cancer
Bone Metastases
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Precision Medicine in Oncology
®
Sarcomas
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Neoadjuvant HER2+
More >>
OncLive TV: Matthew R. Cooperberg, MD, MPH
<< Back to Our Featured Experts
Dr. Cooperberg on Ongoing Trials in Early Prostate Cancer
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Abdulraheem Yacoub, MD
Kosj Yamoah, MD
James C. Yang, MD
Jay Yang, MD
Zhi Zhang Yang, MD
Francis Yao, MD
James C. Yao, MD
Katharine Yao, MD
Stanley Yap, MD
Denise Yardley, MD
Denise A. Yardley, MD
Rozita Yarmand, PhD
Christopher A. Yasenchak, MD
Victor Y. Yazbeck, MD
Douglas Yee, MD
Todd A. Yezefski, MD
Ken Y. Yoneda, MD
Harry H. Yoon, MD
Anas Younes, MD
Guy Young, MD
Benjamin A. Youngblood, PhD
Evan Y. Yu, MD
Helena A. Yu, MD
James B. Yu, MD
Peter Yu, MD
RuiRong Yuan, MD, PhD
Bertram Yuh, MD
Rex Chin-Wei Yung, MD
Matthew Yurgelun, MD
Matthew B. Yurgelun, MD
FDA Approvals in Myeloma and aTTP, Priority Review Designations in RCC and HNSCC, and More
Trending Now
Novel Agents Spark New Approaches for Triple-Negative Breast Cancer
PARP Inhibitors Hold Promise in mCRPC and Biallelic DNA Repair Gene Defects
FDA Approves Adjuvant Pembrolizumab in Stage III Melanoma
Pembrolizumab Shows Promising Activity in Non-Clear Cell RCC
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x